In order to provide a common standard for the treatment of mycosis fungoides (MF) and
Sézary syndrome (SS), the European Organisation for Research and Treatment of Cancer …

Oral lichen planus (OLP) is a chronic inflammatory disorder with a multifactorial
etiopathogenesis. Immune dysregulation plays a critical role in the development and …

Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …

Background Extracorporeal photopheresis (ECP) has emerged as a systemic first-line
immunomodulatory therapy in leukaemic cutaneous T-cell lymphoma (L-CTCL) and is now …

Background aims Mesenchymal stromal cells (MSC) are ideal candidates for regenerative
and immunomodulatory therapies. The use of xenogeneic protein–free Good Manufacturing …

Extracorporeal photopheresis (ECP) is an immunomodulatory alternative for treatment of
graft versus host disease (GVHD). The blood is then separated into its various components …

Cutaneous T-cell lymphoma (CTCL) is a broad term describing cancers of the T cell
whereby the skin is the primary organ of involvement. Although the disease was first …

Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …

Mycosis fungoides (MF) is a low-grade cutaneous lymphoma accounting for more than half
of primary cutaneous T-cell lymphomas (CTCLs). Due to the rarity of CTCL, randomized …